Fox Chase Cancer Center’s Maggie Erb Recognized With Prestigious 2024 DAISY Nurse Leader of the Year Award

Daisy Award 2024
Maggie Erb, MSN, RN, a Medical Oncology Clinical Manager at Fox Chase Cancer Center, was recently honored with the Pennsylvania Organization of Nurse Leaders’ (PONL) 2024 DAISY Nurse Leader of the Year Award.

PHILADELPHIA (November 8, 2024) — Maggie Erb, MSN, RN, a Medical Oncology Clinical Manager at Fox Chase Cancer Center, was recently honored with the Pennsylvania Organization of Nurse Leaders’ (PONL) 2024 DAISY Nurse Leader of the Year Award.

“I am thrilled to have been selected as the recipient of this prestigious award,” said Erb. “To be honored for work that directly impacts both patients and staff in a positive way is always appreciated. I am eager to continue this fulfilling work and am grateful for this truly special recognition.”  

The DAISY Nurse Leader of the Year Award was created to recognize those who create a compassionate environment through skillful care but who are not typically involved in direct patient care. The award recognizes nurse managers, directors, assistant managers, charge nurses, chief nursing officers, informatics nurses, and patient flow nurses throughout Pennsylvania.  

“Maggie’s leadership stretches beyond the corridors of her unit. She is a nursing resource for colleagues caring for medical oncology inpatients and often responds to questions regarding goals of care, multidisciplinary communication, length of stay, as well as inpatient chemotherapy regimens across the cancer center,” Susan Rux, PhD, DNP, RN, CENP, FACHE, NEA-BC, Associate Vice President, Professional Nursing Practice and Research at Temple Health, noted in Erb’s nomination letter.

Award winners are typically nominated by staff or coworkers who can attest to their ability to provide quality, compassionate care. Blind nominations are then reviewed against criteria that include advocating for their teams, creating compassionate care environments, and being accessible and responsive to team needs, among other criteria.

“Within the past year, Maggie completed the Oncology Nursing Society Fundamentals of Chemotherapy and Immunotherapy Administration Program, thus role modeling to the novice nurses as well as other nurses throughout the inpatient setting that this education, while extremely valuable to the care they provide to patients each day, is also attainable,” Rux noted.

“Maggie identified gaps in communication related to inpatient chemotherapy admissions and created and shared a tracking document for scheduled chemotherapy admissions with hospitalists, patient flow, and nursing supervisors. This strategy ensured that admission orders were placed, beds reserved, and appropriate staffing attained,” she added.

In addition to her role as Medical Oncology Clinical Manager, Erb serves as Chair of the Nursing Performance Improvement Council and works tirelessly on process improvement and zero harm initiatives, patient satisfaction, and staff engagement. She has co-authored abstracts and presented at multiple national conferences.

Erb was celebrated at the PONL annual conference on September 27. In addition to receiving the esteemed Healer’s Touch sculpture, she was granted a one-year paid membership to PONL, providing valuable resources and networking opportunities.  

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427